As revealed by PCR gene array and RNA sequencing, TGF-β signaling pathway was activated both in JAM-A-transfected B-lymphoma cells (Fig. 4A) and in DLBCL patients (Fig. 4B). The gene discussed is TGFB1; the disease is diffuse large B-cell lymphoma.